PsychedeLinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Oregon Psilocybin Services Act
In mad dash, Oregon psilocybin centers face bans across the state before any have opened
Despite voters approving Measure 109 two years ago, much of Oregon could lose access to therapy.
Oregonians in dozens of counties, cities will vote on psilocybin bans in November – Oregon Capital Chronicle
Despite voting two years ago to legalize psilocybin therapy, some Oregonians will vote on local bans in November.
Right to Try
Dying Patients Are Fighting for Access to Psychedelics
Advocates argue that terminal patients should be able to get psilocybin and MDMA through the Right to Try law
Science, Therapy, & Research
Genetic variants cause different reactions to psychedelic therapy
The variants could explain why some patients fare much better after treatment than others, says School of Medicine’s Dr. Bryan Roth.
Psychedelics May Lessen Fear of Death and Dying
Both those who experienced a natural near-death experience and those who had a near-death experience while taking psychedelics report less fear of death and a lasting, spiritual positive experience.
Psilocybin May Help Treat Alcohol Addiction, Study Shows
New research finds promise for the psychedelic drug
Get Ready for the Magic Mushroom Pill
The medical benefits of psychedelic drugs have gone from Age of Aquarius punchline to solid science, but the startups racing to market might still be getting ahead of themselves.
Are Hallucinogen Look-Alikes Illegal? DEA Delay Creates Limbo
Welcome to this week’s look at the cannabis and psychedelics industries. It’s been clear for a while that psychedelics companies face big challenges in the race to identify and patent substances that resemble classic drugs like psilocybin and LSD. But the regulatory twists this summer have just uppe…
Business
Ketamine’s upgrade to an employee benefit in US may hasten the legitimacy of psychedelics in SA
Psychedelics like ketamine and psilocybin - the active ingredient in ‘magic mushrooms’ - are shedding their previously prohibited status.
Psychedelics Companies Turn Focus To Resilience
To talk about resilience in the psychedelics industry is a bit premature, but it’s the perfect time to build a foundation for resilience.
Culture
Use of Marijuana and Psychedelics Is Soaring Among Young Adults, Study Finds
The annual U.S. survey of substance use captures the growing mainstream acceptance of cannabis and hallucinogenic compounds.
Subscribe
Subscribe to PsychedeLinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
